Back to Search
Start Over
Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs
- Source :
- American Journal of Cancer Research, American Journal of Cancer Research, 2022, 12 (3), pp.1116-1128. ⟨10.3390/diagnostics12020388⟩, Diagnostics, Diagnostics, MDPI, 2022, 12 (2), pp.388. ⟨10.3390/diagnostics12020388⟩, American Journal of Cancer Research, e-Century Publishing, 2022, 12 (3), pp.1116-1128. ⟨10.3390/diagnostics12020388⟩, Diagnostics; Volume 12; Issue 2; Pages: 388
- Publication Year :
- 2022
- Publisher :
- HAL CCSD, 2022.
-
Abstract
- International audience; An increasing number of studies concerning solid cancers, including prostate cancer, are tending to demonstrate the predominant role of the interactions of tumor cells with their microenvironment, and underlining the relevance of therapeutic approaches co-targeting these two components. Artificial in vitro 3D culture models, such as spheroids, are therefore being designed to allow intercellular interactions between tumor cells and the matrix, under hypoxic conditions mimicking a microtumor. This project aims to develop and characterize a multicellular tumor spheroid (MCTS) model of human prostate cancer cells expressing PSMA, for in vitro drug screening. To this end, 1,000 cells/well were seeded in 100 µl of culture medium with 0.5% of methylcellulose in 96-well, non-adherent, V-shaped bottom plates. Bioluminescent imaging of the spheroids enabled the measurement of spheroid growth. From Day 7 of growth, immunofluorescence studies showed cellular proliferation (Ki-67), mainly located in the periphery of the spheroid section, associated with the formation of an apoptotic core (TUNEL). Scanning electron microscopy and fluorescent imaging (Lox-1 probe) showed the presence of an extracellular matrix and the installation of an oxygen gradient leading to the formation of a hypoxic area during growth. This hypoxia was correlated with increased VEGF excretion. Drug sensitivity was assessed on 2D and 3D cultures. The LNCaP-Luc spheroids are more resistant to docetaxel and TH-302, a hypoxia-activated prodrug, compared with cells grown in a monolayer. For docetaxel, this resistance increased with the spheroid growth stage, whereas the activity of TH-302 was potentiated by the hypoxic environment. In conclusion, the development of LNCaP-Luc cell MCTS provides a simple model mimicking a microtumor; it appears to be particularly well-suited to the validation of new therapeutic approaches targeting proliferation and the microenvironment.
- Subjects :
- B16 melanoma tumor
[SDV]Life Sciences [q-bio]
Clinical Biochemistry
MESH: Epigenome
[SDV.CAN]Life Sciences [q-bio]/Cancer
high-resolution magic angle spinning
global methylome
18F-FDG PET
radiomics
machine-learning
immunotherapy
melanoma
prediction
2D 1H−13C NMR spectroscopy
MESH: Animals
MESH: Metabolomics
MESH: Mice
MESH: Vitamin U
Prostate cancer
hypoxia
B16 melanoma cell culture
metabolomics
MESH: Melanoma, Experimental
spheroid
MESH: Methionine
orthogonal partial least squares discriminant analysis
l-[13C-methyl]methionine
methyl metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 21566976 and 20754418
- Database :
- OpenAIRE
- Journal :
- American Journal of Cancer Research, American Journal of Cancer Research, 2022, 12 (3), pp.1116-1128. ⟨10.3390/diagnostics12020388⟩, Diagnostics, Diagnostics, MDPI, 2022, 12 (2), pp.388. ⟨10.3390/diagnostics12020388⟩, American Journal of Cancer Research, e-Century Publishing, 2022, 12 (3), pp.1116-1128. ⟨10.3390/diagnostics12020388⟩, Diagnostics; Volume 12; Issue 2; Pages: 388
- Accession number :
- edsair.doi.dedup.....da55e27547f0a152934851e54fea0029